Beneficial effects of oral clodronate in the management of malignant osteolysis and hypercalcaemia.
Aranko
K
K
Hanhijärvi
H
H
Humphreys
M
M
Drake
J
J
Lawton
W A
WA
D001682:Biological Availability; D004002:Clodronic Acid / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D010014:Osteolysis / Q000188:drug therapy*; D011446:Prospective Studies; D013810:Therapeutic Equivalency
D004002:Clodronic Acid